Multidisciplinary Reviews in Malignant Hematology - Multiple Myeloma 2024

Friday, September 20, 2024, 7:30 AM - 2:00 PM, OFP Gilmour Center, Detroit, MI


AMA PRA Category 1 Credits™ (5.00 hours), AMA PRA Non-Physician Attendance (5.00 hours)

The field of Plasma Cell Disorders (Multiple Myeloma), its diagnosis, and multidisciplinary management is a constantly evolving field. Over the recent past we have witnessed how an enhanced classification system has helped us better assess disease biology/function for earlier therapeutic intervention, while a deeper understanding of the underlying disease mechanisms has in turn informed us of the ways in which we can devise management strategies using traditional, targeted, immunomodulatory, and cellular therapies. This update is intended to enhance our understanding of the mechanisms behind the development and progression of plasma cell disorders, in particular multiple myeloma, the ways in which they are now being treated, their resistance pathways, and the ever-increasing novel management concepts being tested in the lab and clinic. The hope is that we can come away from this conference with a better understanding of these disorders and use this knowledge to both further the field and better help in the care of our patients.

1. Understand the morphologic and cytogenetic evaluation of Multiple Myeloma
2. Evaluate multi-modality management of plasmacytoma, as well as newly diagnosed and relapsed multiple myeloma.
3. Assess the sequencing of T-cell directed therapy in Multiple Myeloma
4. Conceptualize how newer treatment modalities might modify standards of care in the near future

Henry Ford Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

 

DESIGNATION STATEMENT:

Henry Ford Health designates this live course for a maximum of 5.00 AMA PRA Category 1 Credit(s) TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.

 

FACULTY/PLANNING COMMITTEE DISCLOSURE STATEMENT: 

 In compliance with the ACCME standards for Commercial Support, all individuals in a position to control/influence the content of this activity are required to disclose all financial interests of their own with any ACCME defined commercial interests for the past 24 months and/or non-FDA approved use of a drug or a device that is included in the presentation. All financial relationships have been mitigated prior to the commencement of the activity.

 

ACCESSIBILITY STATEMENT: 

Henry Ford Health provides qualified interpreters and other aids for Deaf, DeafBlind, and Hard-of-Hearing persons at no cost. To request assistance, contact the event coordinator: [email protected]. Please allow a minimum of 3 days to process this request.

Cancellation Policy

Please send cancellation requests to [email protected].

Henry Ford Health Office of Continuing Medical Education reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred such as non-refundable airline tickets or hotel penalties.

The Henry Ford Health Office of Continuing Medical Education adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Henry Ford Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.